UnitedHealth reported fourth-quarter results on Thursday that reflected persistent challenges for the health insurance sector ...

In his first public comments since one of his executives was shot to death, UnitedHealth Group CEO Andrew Witty said the ...

Doxycycline postexposure prophylaxis has the potential to substantially reduce real-world population-level incidence of ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...

At the top of that list, unsurprisingly, are Novo Nordisk obesity drugs Ozempic, Rybelsus, and Wegovy, all grouped together ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...

Legal-Bay LLC, a leading pre settlement funding company, reports that November's $2.2 billion ruling against GlaxoSmithKline has still not been distributed to 80,000+ Zantac plaintiffs. The UK-based ...

We recently compiled a list of the 12 Cheapest Stocks with Biggest Upside Potential. In this article, we are going to take a ...

The High Court ruled on a significant patent dispute involving Pfizer and GSK, addressing costs and confidentiality.

A degree in Science, Technology, Engineering, or Mathematics (STEM) offers access to high-demand careers in innovation-driven ...

In a report released on January 9, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...